Psychiatry · Houston, TX
NPI
1760546360
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7505 Fannin St Ste 170
Houston, TX, 77054
Phone (832) 786-9141
Groups this clinician bills Medicare through
Medicare paid, 2024
$251K
4,574 services
Medicare patients, 2024
243
Average age 56
Drug cost, 2024
$3.0M
10,134 prescriptions
Company payments, 2025
$66K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ignacio H Valdes was code 99232 (hospital e&m - subsequent), 3,281 times for 57 patients. In total Ignacio H Valdes billed 4,574 services in 12 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 3,281 | 57 | $53.41 | $175K |
| 99214 Office E&M - Established | Office | 526 | 124 | $79.78 | $42K |
| 99213 Office E&M - Established | Office | 165 | 68 | $53.84 | $8,883 |
| 90853 Psychotherapy - Group | Facility | 103 | 14 | $17.10 | $1,762 |
| 90832 Psychotherapy - Nongroup | Facility | 72 | 14 | $46.66 | $3,360 |
| 90792 Psychotherapy - Nongroup | Office | 45 | 44 | $114.19 | $5,138 |
| 99222 Hospital E&M - Initial | Facility | 41 | 36 | $84.81 | $3,477 |
| 99238 Hospital Discharge Management | Facility | 32 | 29 | $54.16 | $1,733 |
By year: 2022 $743K for 15,492 services; 2023 $412K for 7,528 services; 2024 $251K for 4,574 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ignacio H Valdes prescribed most often to Medicare patients was Quetiapine Fumarate, with 740 prescriptions and refills. In total Ignacio H Valdes wrote 10,134 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Quetiapine Fumarate Generic | 740 | 762 | 143 | $11K |
| Benztropine Mesylate Generic | 518 | 551 | 117 | $5,840 |
| Trazodone Hcl Generic | 511 | 544 | 132 | $2,775 |
| Mirtazapine Generic | 511 | 517 | 129 | $4,817 |
| Buspirone Hcl Generic | 391 | 405 | 89 | $4,793 |
| Divalproex Sodium Er Divalproex Sodium | 349 | 369 | 81 | $11K |
| Sertraline Hcl Generic | 342 | 371 | 87 | $1,425 |
| Risperidone Generic | 342 | 379 | 76 | $4,680 |
| Clonazepam Generic | 312 | 318 | 64 | $2,339 |
| Invega Sustenna Paliperidone Palmitate | 285 | 286 | 57 | $866K |
| Gabapentin Generic | 254 | 266 | 74 | $3,226 |
| Hydroxyzine Hcl Generic | 248 | 254 | 74 | $4,183 |
| Lithium Carbonate Generic | 244 | 245 | 60 | $1,503 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 216 | 217 | 63 | $15K |
| Aripiprazole Generic | 209 | 225 | 61 | $14K |
Brand drugs: - claims; generic drugs: 8,840 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ignacio H Valdes $66K ($66K in general payments such as food, travel and fees) from 19 companies. The largest payer was Neurocrine BioSciences, Inc. with $26K.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 49 | $26K |
| Teva Pharmaceuticals USA, Inc. TEVA | 56 | $22K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 40 | $16K |
| E.R. Squibb & Sons, L.L.C. BMY | 24 | $417 |
| Alkermes, Inc. ALKS | 20 | $411 |
| Vanda Pharmaceuticals Inc. VNDA | 15 | $321 |
| Janssen Pharmaceuticals, Inc JNJ | 11 | $295 |
| Lundbeck LLC | 8 | $159 |
| Supernus Pharmaceuticals, Inc. SUPN | 5 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $67.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.